K. A. NEWLANDER

1.3k total citations
9 papers, 543 citations indexed

About

K. A. NEWLANDER is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, K. A. NEWLANDER has authored 9 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in K. A. NEWLANDER's work include Chemical Synthesis and Analysis (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Neuropeptides and Animal Physiology (2 papers). K. A. NEWLANDER is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Neuropeptides and Animal Physiology (2 papers). K. A. NEWLANDER collaborates with scholars based in United States. K. A. NEWLANDER's co-authors include Anita Hong, G. A. Reynolds, Frank A. Momany, C. Y. Bowers, D. Chang, William F. Huffman, Jerry L. Adams, Zhihong Lai, Denis R. Patrick and Jingsong Yang and has published in prestigious journals such as Biochemical Journal, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

K. A. NEWLANDER

9 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. A. NEWLANDER United States	7	226	197	127	122	95	9	543
Stella Clark Australia	17	130 0.6×	532 2.7×	70 0.6×	58 0.5×	96 1.0×	41	836
Barbara J. Palazuk United States	10	76 0.3×	421 2.1×	61 0.5×	43 0.4×	35 0.4×	10	683
Marvin D. Bregman United States	15	154 0.7×	358 1.8×	33 0.3×	67 0.5×	111 1.2×	27	651
John W. Koontz United States	11	144 0.6×	419 2.1×	38 0.3×	29 0.2×	73 0.8×	26	669
Christopher M. Moxham United States	9	67 0.3×	464 2.4×	33 0.3×	33 0.3×	52 0.5×	10	677
Christina Rye Underwood Denmark	11	260 1.2×	497 2.5×	56 0.4×	48 0.4×	24 0.3×	16	653
P. Thamm Germany	9	74 0.3×	342 1.7×	32 0.3×	23 0.2×	108 1.1×	9	496
Clement W.T. Yeung Canada	8	90 0.4×	420 2.1×	19 0.1×	28 0.2×	84 0.9×	13	567
Kozo Ishidate Japan	16	61 0.3×	500 2.5×	14 0.1×	85 0.7×	83 0.9×	29	754
K. Y. Wong United States	13	217 1.0×	537 2.7×	16 0.1×	138 1.1×	110 1.2×	14	908

Countries citing papers authored by K. A. NEWLANDER

Since Specialization

Citations

This map shows the geographic impact of K. A. NEWLANDER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. NEWLANDER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. NEWLANDER more than expected).

Fields of papers citing papers by K. A. NEWLANDER

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. NEWLANDER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. NEWLANDER. The network helps show where K. A. NEWLANDER may publish in the future.

Co-authorship network of co-authors of K. A. NEWLANDER

This figure shows the co-authorship network connecting the top 25 collaborators of K. A. NEWLANDER. A scholar is included among the top collaborators of K. A. NEWLANDER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. A. NEWLANDER. K. A. NEWLANDER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tian, Xinrong, K. A. NEWLANDER, Louis V. LaFrance, et al.. (2025). Asymmetric synthesis of potent and orally bioavailable thiophene-based EZH2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 127. 130291–130291. 1 indexed citations

Hardwicke, Mary Ann, Catherine A. Oleykowski, Ramona Plant, et al.. (2009). GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models. Molecular Cancer Therapeutics. 8(7). 1808–1817. 89 indexed citations

Lai, Zhihong, Octerloney B. McDonald, J. Darren Stuart, et al.. (2009). Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1. Biochemical Journal. 420(2). 259–265. 45 indexed citations

Lark, Michael W., George B. Stroup, Shing Mei Hwang, et al.. (1999). Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis. Journal of Pharmacology and Experimental Therapeutics. 291(2). 612–617. 37 indexed citations

Ward, Keith W., Leonard M. Azzarano, William E. Bondinell, et al.. (1999). Preclinical Pharmacokinetics and Interspecies Scaling of a Novel Vitronectin Receptor Antagonist. Drug Metabolism and Disposition. 27(11). 1232–1241. 33 indexed citations

NEWLANDER, K. A., James F. Callahan, M. Lane Moore, Thaddeus A. Tomaszek, & William F. Huffman. (1994). ChemInform Abstract: A Novel Constrained Reduced‐Amide Inhibitor of HIV‐1 Protease Derived from the Sequential Incorporation of γ‐Turn Mimetics into a Model Substrate.. ChemInform. 25(2). 4 indexed citations

NEWLANDER, K. A., James F. Callahan, M. Lane Moore, Thaddeus A. Tomaszek, & William F. Huffman. (1993). A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of .gamma.-turn mimetics into a model substrate. Journal of Medicinal Chemistry. 36(16). 2321–2331. 35 indexed citations

Momany, Frank A., C. Y. Bowers, G. A. Reynolds, Anita Hong, & K. A. NEWLANDER. (1984). Conformational Energy Studies andin Vitroandin VivoActivity Data on Growth Hormone-Releasing Peptides*. Endocrinology. 114(5). 1531–1536. 141 indexed citations

Momany, Frank A., C. Y. Bowers, G. A. Reynolds, et al.. (1981). Design, Synthesis, and Biological Activity of Peptides which Release Growth Hormone in Vitro*. Endocrinology. 108(1). 31–39. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact